USClinicalTrials.govClinical trialNot applicableCompleted
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer
Official record
- Identifier
NCT02432950- Recruiting locations
country
United States- Interventions studied
- Dietary InterventionEducational InterventionLaboratory Biomarker AnalysisQuality-of-Life Assessment
- Lead sponsor
- City of Hope Medical Center
- Target enrolment
- 21 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Completed
- First posted
- May 4, 2015
- Last updated on the registry
- Oct 1, 2026
- Age
- Not provided in the official record
- Sex
- FEMALE
- Study contact
- No public contact is listed on the official record.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Patients with early-stage breast cancer (stage I-III) * Patients who have or have not undergone chemotherapy are both eligible; if the patient has undergone chemotherapy she must have completed adjuvant chemotherapy for \>= 3 months and =\< 5 years prior to study enrollment * Postmenopausal women defined by either: natural menopause with at least one year since last menses, or chemotherapy-induced menopause with at least one year since last menses and follicle-stimulating hormone (FSH) and estradiol levels within the postmenopausal range * Body mass index (BMI) of 25-33 kg/m\^2 * Patients must be willing to adhere to the PNP intervention and the entire 6-month study * All patients must have the ability and the willingness to sign a written informed consent Exclusion Criteria: * Patients who are diabetic * Patients whose BMI falls outside the eligible range (\< 25 kg/m\^2 or \> 33 kg/m\^2) * Patients with stage IV breast cancer * Patients with Rheumatoid Arthritis and other inflammatory diseases that would impact correlative studies
- Indexed under
- Pancreatic Cancer